Chitosans for delivery of nucleic acids

Advanced Drug Delivery Reviews

Volumn 65, Issue 9, 2013, Pages 1234-1270

  Buschmann, Michael D ^a   Merzouki, Abderrazzak ^a   Lavertu, Marc ^a   Thibault, Marc ^a   Jean, Myriam ^a   Darras, Vincent ^a  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

Author keywords

Chitosans; Gene delivery; Nanotechnology; Nucleic acid; Polysaccharide; RNAi

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; GENE THERAPY; GENE TRANSFER; MULTILAYERS; NANOTECHNOLOGY; NUCLEIC ACIDS; POLYSACCHARIDES;

COUPLING ANALYSIS; DELIVERY VECTOR; GENE DELIVERY; RECENT PROGRESS; RNAI; STRUCTURAL PARAMETER; STRUCTURE PERFORMANCE; TRANSFECTION EFFICIENCY;

CHITOSAN;

APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 8; CHITIN; CHITOSAN; DNA VACCINE; ENDOTOXIN; FOCAL ADHESION KINASE; GREEN FLUORESCENT PROTEIN; HEAVY METAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2; JAGGED1; LIPOSOME; MUSCARINIC RECEPTOR; NANOPARTICLE; NEUROPILIN 1; NUCLEIC ACID; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN RET; PROTEIN TYROSINE KINASE; RED FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ACETYLATION; ACIDITY; ALKYLATION; AMIDATION; ARTICLE; BINDING AFFINITY; BIODEGRADATION; BREAST CANCER; CELL MIGRATION; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; COVALENT BOND; CYTOTOXICITY; DEACETYLATION; DEPOLYMERIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; HEMOPHILIA A; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; METHYLATION; MOLECULAR WEIGHT; NEOPLASM; NONHUMAN; OVARY CANCER; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; SOLUBILITY; STOICHIOMETRY; SURFACE PROPERTY; SYNTHESIS; TEMPERATURE; THYROID CARCINOMA; ZETA POTENTIAL;

CHITOSANS; GENE DELIVERY; NANOTECHNOLOGY; NUCLEIC ACID; POLYSACCHARIDE; RNAI;

ANIMALS; CHITOSAN; GENETIC THERAPY; HUMANS; NUCLEIC ACIDS; POLYNUCLEOTIDES; TRANSFECTION;

EID: 84884284917     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.07.005     Document Type: Review

References (451)

1. Friedmann T., Robin R. Gene therapy for human genetic disease?. Science 1972, 175:949-955.
2. Dewey R.A., Morrissey G., Cowsill C.M., Stone D., Bolognani F., Dodd N.J.F., Southgate T.D., Klatzmann D., Lassmann H., Castro M.G., Lowenstein P.R. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials. Nat. Med. 1999, 5:1256-1263.
3. Fox J.L. Gene-therapy death prompts broad civil lawsuit. Nat. Biotechnol. 2000, 18:1136.
4. Niidome T., Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 2002, 9:1647-1652.
5. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
6. de Fougerolles A., Vornlocher H.P., Maraganore J., Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discovery 2007, 6:443-453.
7. Mulligan R., Howard B., Berg P. Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature 1979, 277:108-114.
8. Filion D., Lavertu M., Buschmann M.D. Ionization and solubility of chitosan solutions related to thermosensitive chitosan/glycerol-phosphate systems. Biomacromolecules 2007, 8:3224-3234.
9. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 2006, 114:100-109.
10. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7297-7301.
11. Ishii T., Okahata Y., Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta, Biomembr. 2001, 1514:51-64.
12. Lee M., Nah J.W., Kwon Y., Koh J.J., Ko K.S., Kim S.W. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm. Res. 2001, 18:427-431.
13. Issa M.M., Koping-Hoggard M., Tommeraas K., Varum K.M., Christensen B.E., Strand S.P., Artursson P. Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J. Control. Release 2006, 115:103-112.
14. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.O., Hovgaard M.B., Schmitz A., Nyengaard J.R., Besenbacher F., Kjems J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 2006, 14:476-484.
15. Al-Dosari M.S., Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 2009, 11:671-681.
16. Garcia-Fuentes M., Alonso M.J. Chitosan-based drug nanocarriers: where do we stand?. J. Control. Release 2012, 161:496-504.
17. Kean T., Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev. 2010, 62:3-11.
18. Muzzarelli R.A.A. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr. Polym. 2009, 76:167-182.
19. Hoemann C.D., Sun J., Legare A., McKee M.D., Buschmann M.D. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr. Cartil. 2005, 13:318-329.
20. Chevrier A., Hoemann C.D., Sun J., Buschmann M.D. Chitosan-glycerol phosphate/blood implants increase cell recruitment, transient vascularization and subchondral bone remodeling in drilled cartilage defects. Osteoarthr. Cartil. 2007, 15:316-327.
21. Chevrier A., Hoemann C.D., Sun J., Buschmann M.D. Temporal and spatial modulation of chondrogenic foci in subchondral microdrill holes by chitosan-glycerol phosphate/blood implants. Osteoarthr. Cartil. 2011, 19:136-144.
22. Hoemann C.D., Sun J., McKee M.D., Chevrier A., Rossomacha E., Rivard G.E., Hurtig M., Buschmann M.D. Chitosan-glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects. Osteoarthr. Cartil. 2007, 15:78-89.
23. Iliescu M., Hoemann C.D., Shive M.S., Chenite A., Buschmann M.D. Ultrastructure of hybrid chitosan-glycerol phosphate blood clots by environmental scanning electron microscopy. Microsc. Res. Tech. 2008, 71:236-247.
24. Hoemann C.D., Chen G., Marchand C., Tran-Khanh N., Thibault M., Chevrier A., Sun J., Shive M.S., Fernandes M.J., Poubelle P.E., Centola M., El-Gabalawy H. Scaffold-guided subchondral bone repair: implication of neutrophils and alternatively activated arginase-1+ macrophages. Am. J. Sports Med. 2010, 38:1845-1856.
25. Piramal_Healthcare EU market approval: Piramal Enterprises Presents Positive Results of Pivotal Phase III Clinical Trial for BST-CarGel® at the World Congress of the International Cartilage Repair Society (ICRS) 2012, Press Release.
26. Lavertu M., Methot S., Tran-Khanh N., Buschmann M.D. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 2006, 27:4815-4824.
27. Malmo J., Sorgard H., Varum K.M., Strand S.P. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing. J. Control. Release 2012, 158:261-268.
28. Strand S.P., Danielsen S., Christensen B.E., Varum K.M. Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes. Biomacromolecules 2005, 6:3357-3366.
29. Park J.H., Saravanakumar G., Kim K., Kwon I.C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 2010, 62:28-41.
30. Rudzinski W.E., Aminabhavi T.M. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm. 2010, 399:1-11.
31. Mao S., Sun W., Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Deliv. Rev. 2010, 62:12-27.
32. Braconnot H. Recherches analytiques sur la nature des Champignons. Ann. Chim. 1811, 79:265-304.
33. Rouget C. Des substances amylacées dans des animaux, spécialement des Articulés (chitine). Compte Rendus 1859, 48:792-795.
34. Islam M.S., Khan S., Tanaka M. Waste loading in shrimp and fish processing effluents: potential source of hazards to the coastal and nearshore environments. Mar. Pollut. Bull. 2004, 49:103-110.
35. Beaney P., Lizardi-Mendoza J., Healy M. Comparison of chitins produced by chemical and bioprocessing methods. J. Chem. Technol. Biotechnol. 2005, 80:145-150.
36. Brück W.M., Slater J.W., Carney B.F. Chitin and chitosan from marine organisms. Chitin, Chitosan, Oligosaccharides and Their Derivatives 2011, 11-23. CRC Press, Boca Raton. S.-K. Kim (Ed.).
37. Kurita K. Chitin and chitosan: functional biopolymers from marine crustaceans. Mar. Biotechnol. 2006, 8:203-226.
38. Nwe N., Furuike T., Tamura H. Chitin and chitosan from terrestrial organisms. Chitin, Chitosan, Oligosaccharides and Their Derivatives 2011, 3-10. CRC Press, Boca Raton. S.-K. Kim (Ed.).
39. Rødde R.H., Einbu A., Vårum K.M. A seasonal study of the chemical composition and chitin quality of shrimp shells obtained from northern shrimp (Pandalus borealis). Carbohydr. Polym. 2008, 71:388-393.
40. Nemtsev S.V., Zueva O.Y., Khismatullin M.R., Albulov A.I., Varlamov V.P. Isolation of Chitin and Chitosan from honeybees. Appl. Biochem. Microbiol. 2004, 40:39-43.
41. Paulino A.T., Simionato J.I., Garcia J.C., Nozaki J. Characterization of chitosan and chitin produced from silkworm crysalides. Carbohydr. Polym. 2006, 64:98-103.
42. Knezevic-Jugovic Z., Petronijevic Z., Smelcerovic A. Chitin and chitosan from microorganisms. Chitin, Chitosan, Oligosaccharides and Their Derivatives 2011, 25-36. CRC Press, Boca Raton. S.-K. Kim (Ed.).
43. Chatterjee S., Adhya M., Guha A.K., Chatterjee B.P. Chitosan from Mucor rouxii: production and physico-chemical characterization. Process. Biochem. 2005, 40:395-400.
44. Stamford T.C.M., Stamford T.L.M., Stamford N.P., Neto B.d.B., Campos-Takaki G.M.d. Growth of Cunninghamella elegans UCP 542 and production of chitin and chitosan using yam bean medium 2007, 10:61-68.
45. Sietsma J.H., Wessels J.G.H. Solubility of (1→3)-β-D/(1→6)-β-D-glucan in fungal walls: importance of presumed linkage between glucan and chitin. J. Gen. Microbiol. 1981, 125:209-212.
46. Muzzarelli R.A.A., Tanfani F., Scarpini G. Chelating, film-forming, and coagulating ability of the chitosan-glucan complex from Aspergillus niger industrial wastes. Biotechnol. Bioeng. 1980, 22:885-896.
47. Rinaudo M. Chitin and chitosan: properties and applications. Prog. Polym. Sci. 2006, 31:603-632.
48. Rudall K.M. Chitin and its association with other molecules. J. Polym. Sci., Part C 1969, 28:83-102.
49. Gaill F., Persson J., Sugiyama J., Vuong R., Chanzy H. The chitin system in the tubes of deep sea hydrothermal vent worms. J. Struct. Biol. 1992, 109:116-128.
50. Blackwell J., Parker K.D., Rudall K.M. Chitin in pogonophore tubes. J. Mar. Biol. Assoc. U. K. 1965, 45:659-661.
51. Rudall K.M. Skeletal structure in insects. Biochem. Soc. Symp. 1965, 25:83-92.
52. Roberts G.A.F. Chitin chemistry 1992, Macmillian, London.
53. Atkins E. Conformations in polysaccharides and complex carbohydrates. J. Biosci. 1985, 8:375-387.
54. Minke R., Blackwell J. The structure of α-chitin. J. Mol. Biol. 1978, 120:167-181.
55. Lotmar W., Picken L. A new crystallographic modification of chitin and its distribution. Cellular and Molecular Life Sciences 1950, 6:58-59.
56. Rudall K.M. The chitin/protein complexes of insect cuticles. Adv. Insect. Physiol 1963, 1:257-313. (J. W. L. Beament, J. E. Treherne, and V. B. Wigglesworth, editors. Academic).
57. Saito Y., Putaux J.L., Okano T., Gaill F., Chanzy H. Structural Aspects of the Swelling of β Chitin in HCl and its Conversion into α Chitin. Macromolecules 1997, 30:3867-3873.
58. Percot A., Viton C., Domard A. Optimization of chitin extraction from shrimp shells. Biomacromolecules 2002, 4:12-18.
59. Galed G., Diaz E., Goycoolea F.M., Heras A. Influence of N-deacetylation conditions on chitosan production from α-chitin. Nat. Prod. Commun. 2008, 3:543-550.
60. Ottøy M.H., Vårum K.M., Smidsrød O. Compositional heterogeneity of heterogeneously deacetylated chitosans. Carbohydr. Polym. 1996, 29:17-24.
61. G.I. Krepets, A.Y. Mikhailin, Method of chitin and chitosan production from chitin-containing raw materials, US Pat. 5,053,113.
62. Jo G.-H., Park R.-D., Jung W.-J. Enzymatic production of chitin from crustacean shell waste. Chitin, Chitosan, Oligosaccharides and Their Derivatives 2011, 37-45. CRC Press, Boca Raton. S.-K. Kim (Ed.).
63. Pacheco N., Garnica-Gonzalez M.N., Gimeno M., Bárzana E., Trombotto S.P., David L., Shirai K. Structural Characterization of Chitin and Chitosan Obtained by Biological and Chemical Methods. Biomacromolecules 2011, 12:3285-3290.
64. Rao M.S., Stevens W.F. Chitin production by Lactobacillus fermentation of shrimp biowaste in a drum reactor and its chemical conversion to chitosan. J. Chem. Technol. Biotechnol. 2005, 80:1080-1087.
65. Kumar M.N.V.R., Muzzarelli R.A.A., Muzzarelli C., Sashiwa H., Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 2004, 104:6017-6084.
66. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., August J.T., Leong K.W. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release 2001, 70:399-421.
67. Kim T.-H., Jiang H.-L., Jere D., Park I.-K., Cho M.-H., Nah J.-W., Choi Y.-J., Akaike T., Cho C.-S. Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog. Polym. Sci. 2007, 32:726-753.
68. Shigemasa Y., Saito K., Sashiwa H., Saimoto H. Enzymatic degradation of chitins and partially deacetylated chitins. Int. J. Biol. Macromol. 1994, 16:43-49.
69. Aiba S. Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated chitosans. Int. J. Biol. Macromol. 1992, 14:225-228.
70. Aiba S. Studies on chitosan: 3. Evidence for the presence of random and block copolymer structures in partially N-acetylated chitosans. Int. J. Biol. Macromol. 1991, 13:40-44.
71. Kurita K., Sannan T., Iwakura Y. Studies on chitin, 4 - Evidence for formation of block and random copolymers of N-Acetyl-D-glucosamine and D-glucosamine by hetero- and homogeneous hydrolyses. Makromol. Chem. 1977, 178:3197-3202.
72. Vårum K.M., Antohonsen M.W., Grasdalen H., Smidsrød O. Determination of the degree of N-acetylation and the distribution of N-acetyl groups in partially N-deacetylated chitins (chitosans) by high-field n.m.r. spectroscopy. Carbohydr. Res. 1991, 211:17-23.
73. Vårum K.M., Anthonsen M.W., Grasdalen H., Smidsrød O. 13C-N.m.r. studies of the acetylation sequences in partially N-deacetylated chitins (chitosans). Carbohydr. Res. 1991, 217:19-27.
74. Lamarque G., Viton C., Domard A. Comparative Study of the first heterogeneous deacetylation of α- and β-chitins in a multistep process. Biomacromolecules 2004, 5:992-1001.
75. Lamarque G., Viton C., Domard A. Comparative study of the second and third heterogeneous deacetylations of α- and β-chitins in a multistep process. Biomacromolecules 2004, 5:1899-1907.
76. Lamarque G., Cretenet M., Viton C., Domard A. New route of deacetylation of α- and β-chitins by means of freeze-pump out-thaw cycles. Biomacromolecules 2005, 6:1380-1388.
77. Sannan T., Kurita K., Iwakura Y. Studies on chitin, 1 - Solubility change by alkaline treatment and film casting Die. Makromol. Chem. 1975, 176:1191-1195.
78. Sannan T., Kurita K., Iwakura Y. Studies on chitin, 2 - Effect of deacetylation on solubility. Makromol. Chem. 1976, 177:3589-3600.
79. Lavertu M., Darras V., Buschmann M.D. Kinetics and efficiency of chitosan reacetylation. Carbohydr. Polym. 2012, 87:1192-1198.
80. Berger J., Reist M., Chenite A., Felt-Baeyens O., Mayer J.M., Gurny R. Pseudo-thermosetting chitosan hydrogels for biomedical application. Int. J. Pharm. 2005, 288:17-25.
81. Vachoud L., Zydowicz N., Domard A. Formation and characterisation of a physical chitin gel. Carbohydr. Res. 1997, 302:169-177.
82. Qun G., Ajun W., Yong Z. Effect of reacetylation and degradation on the chemical and crystal structures of chitosan. J. Appl. Polym. Sci. 2007, 104:2720-2728.
83. Zhao Y., Ju W.-T., Park R.-D. Enzymatic modifications of chitin and chitosan. Chitin, Chitosan, Oligosaccharides and Their Derivatives 2011, 185-192. CRC Press, Boca Raton. S.-K. Kim (Ed.).
84. John M., Roehrig H., Schmidt J., Wieneke U., Schell J. Rhizobium NodB protein involved in nodulation signal synthesis is a chitooligosaccharide deacetylase. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:625-629.
85. Vollmer W., Tomasz A. The pgdA gene encodes for a peptidoglycanN-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 2000, 275:20496-20501.
86. Tokuyasu K., Ono H., Ohnishi-Kameyama M., Hayashi K., Mori Y. Deacetylation of chitin oligosaccharides of dp 2-4 by chitin deacetylase from Colletotrichum lindemuthianum. Carbohydr. Res. 1997, 303:353-358.
87. Aye K.N., Karuppuswamy R., Ahamed T., Stevens W.F. Peripheral enzymatic deacetylation of chitin and reprecipitated chitin particles. Bioresour. Technol. 2006, 97:577-582.
88. Huang M., Fong C.-W., Khor E., Lim L.-Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J. Control. Release 2005, 106:391-406.
89. Koping-Hoggard M., Varum K.M., Issa M., Danielsen S., Christensen B.E., Stokke B.T., Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004, 11:1441-1452.
90. Falk M., Smith D.G., McLachlan J., McInnes A.G. Studies on chitan (β-(1→4)-linked 2-acetamido-2-deoxy-d-glucan) fibers of the diatom thalassiosira fluviatilis hustedt: ii. Proton magnetic resonance, infrared, and x-ray studies. Can. J. Chem. 1966, 44:2269-2281.
91. Rupley J.A. The hydrolysis of chitin by concentrated hydrochloric acid and the preparation of low-molecular-weight substrates for lysozyme. Biochem. Biophys. Acta 1964, 83:245-255.
92. Vårum K.M., Kristiansen Holme H., Izume M., Torger Stokke B., Smidsrød O. Determination of enzymatic hydrolysis specificity of partially N-acetylated chitosans. Biochim. Biophys. Acta, Gen. Subj. 1996, 1291:5-15.
93. Vårum K.M., Ottøy M.H., Smidsrød O. Acid hydrolysis of chitosans. Carbohydr. Polym. 2001, 46:89-98.
94. Obaidat R., Al-Jbour N., Al-Sou'd K., Sweidan K., Al-Remawi M., Badwan A. Some physico-chemical properties of low molecular weight chitosans and their relationship to conformation in aqueous solution. J. Solution Chem. 2010, 39:575-588.
95. Richardson S.C., Kolbe H.V., Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 1999, 178:231-243.
96. Fukamizo T., Ohkawa T., Ikeda Y., Goto S. Specificity of chitosanase from Bacillus pumilus. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1994, 1205:183-188.
97. Adachi W., Sakihama Y., Shimizu S., Sunami T., Fukazawa T., Suzuki M., Yatsunami R., Nakamura S., Takénaka A. Crystal structure of family GH-8 chitosanase with subclass II specificity from Bacillus sp. K17. J. Mol. Biol. 2004, 343:785-795.
98. Horn S.J., Sikorski P., Cederkvist J.B., Vaaje-Kolstad G., Sørlie M., Synstad B., Vriend G., Vårum K.M., Eijsink V.G.H. Costs and benefits of processivity in enzymatic degradation of recalcitrant polysaccharides. Proc. Natl. Acad. Sci. 2006, 103:18089-18094.
99. Heggset E.B., Tuveng T.R., Hoell I.A., Liu Z., Eijsink V.G.H., Vårum K.M. Mode of action of a family 75 chitosanase from Streptomyces avermitilis. Biomacromolecules 2012, 13:1733-1741.
100. Allan G.G., Peyron M. The kinetics of the depolymerization of chitosan by nitrous acid. Chitin and Chitosan 1989, 443-466. Elsevier Science Publishers Ltd, London. G. Skjak-Brack, T. Anthonsen, P. Sandford (Eds.).
101. Allan G.G., Peyron M. Molecular weight manipulation of chitosan. I. Kinetics of depolymerization by nitrous acid. Carbohydr. Res. 1995, 277:257-272.
102. Allan G.G., Peyron M. Molecular weight manipulation of chitosan. II. Prediction and control of extent of depolymerization by nitrous acid. Carbohydr. Res. 1995, 277:273-282.
103. Tommeraas K., Varum K.M., Christensen B.E., Smidsrod O. Preparation and characterisation of oligosaccharides produced by nitrous acid depolymerisation of chitosans. Carbohydr. Res. 2001, 333:137-144.
104. Tømmeraas K., Köping-Höggård M., Vårum K.M., Christensen B.E., Artursson P., Smidsrød O. Preparation and characterisation of chitosans with oligosaccharide branches. Carbohydr. Res. 2002, 337:2455-2462.
105. United States Pharmacopeial Convention NF vol. 29 Supplement n°2, "Chitosan", United States Pharmacopeial Convention, 2011, pp. 5361-5365.
106. ASTM Standard F2103 Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications 2011, ASTM International, West Conshohocken, PA, www.astm.org. 10.1520/F2103-11.
107. Lavertu M., Xia Z., Serreqi A.N., Berrada M., Rodrigues A., Wang D., Buschmann M.D., Gupta A. A validated H-1 NMR method for the determination of the degree of deacetylation of chitosan. J. Pharm. Biomed. Anal. 2003, 32:1149-1158.
108. Nordtveit R.J., Vårum K.M., Smidsrød O. Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme. Carbohydr. Polym. 1996, 29:163-167.
109. Jean M., Smaoui F., Lavertu M., Methot S., Bouhdoud L., Buschmann M.D., Merzouki A. Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies. Gene Ther. 2009, 16:1097-1110.
110. Kasaai M.R. Various methods for determination of the degree of N-acetylation of chitin and chitosan: a review. J. Agric. Food Chem. 2009, 57:1667-1676.
111. Muzzarelli R.A.A., Rocchetti R. Determination of the degree of acetylation of chitosans by first derivative ultraviolet spectrophotometry. Carbohydr. Polym. 1985, 5:461-472.
112. Hirai A., Odani H., Nakajima A. Determination of degree of deacetylation of chitosan by proton NMR spectroscopy. Polym. Bull. (Berlin) 1991, 26:87-94.
113. Tan S.C., Khor E., Tan T.K., Wong S.M. The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination. Talanta 1998, 45:713-719.
114. Mao S., Shuai X., Unger F., Wittmar M., Xie X., Kissel T. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials 2005, 26:6343-6356.
115. Weinhold M.X., Sauvageau J.C.M., Kumirska J., Thöming J. Studies on acetylation patterns of different chitosan preparations. Carbohydr. Polym. 2009, 78:678-684.
116. ASTM Standard F2602 Standard Test Method for Determining the Molar Mass of Chitosan and Chitosan Salts by Size Exclusion Chromatography with Multi angle Light Scattering Detection (SEC MALS) 2008, 2008e1, ASTM International, West Conshohocken, PA, www.astm.org. 10.1520/F2602-08E01.
117. Beri R.G., Walker J., Resse E.T., Rollings J.E. Characterization of chitosans via coupled size-exclusion chromatography and multiple-angle laser light-scattering technique. Carbohydr. Res. 1993, 238:11-26.
118. Christensen B.E., Myhr M.H., Aune O., Hagen S., Berge A., Ugelstad J. Macroporous, monodisperse particles and their application in aqueous size exclusion chromatography of high molecular weight polysaccharides. Carbohydr. Polym. 1996, 29:217-223.
119. Wyatt P.J. Light scattering and the absolute characterization of macromolecules. Anal. Chim. Acta 1993, 272:1-40.
120. Wang W., Bo S.Q., Li S.Q., Qin W. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int. J. Biol. Macromol. 1991, 13:281-285.
121. Rinaudo M., Milas M., Dung P.L. Characterization of chitosan. Influence of ionic strength and degree of acetylation on chain expansion. Int. J. Biol. Macromol. 1993, 15:281-285.
122. Ottøy M.H., Vårum K.M., Christensen B.E., Anthonsen M.W., Smidsrød O. Preparative and analytical size-exclusion chromatography of chitosans. Carbohydr. Polym. 1996, 31:253-261.
123. Berth G., Dautzenberg H., Peter M.G. Physico-chemical characterization of chitosans varying in degree of acetylation. Carbohydr. Polym. 1998, 36:205-216.
124. Tsaih M.L., Chen R.H. Molecular weight determination of 83% degree of decetylation chitosan with non-Gaussian and wide range distribution by high-performance size exclusion chromatography and capillary viscometry. J. Appl. Polym. Sci. 1999, 71:1905-1913.
125. Kasaai M.R., Arul J., Charlet G. Intrinsic viscosity-molecular weight relationship for chitosan. J. Polymer Sci., Part B: Polymer Phys. 2000, 38:2591-2598.
126. Berth G., Dautzenberg H. The degree of acetylation of chitosans and its effect on the chain conformation in aqueous solution. Carbohydr. Polym. 2002, 47:39-51.
127. Fee M., Errington N., Jumel K., Illum L., Smith A., Harding S.E. Correlation of SEC/MALLS with ultracentrifuge and viscometric data for chitosans. Eur. Biophys. J. 2003, 32:457-464.
128. Schatz C., Pichot C., Delair T., Viton C., Domard A. Static light scattering studies on chitosan solutions: from macromolecular chains to colloidal dispersions. Langmuir 2003, 19:9896-9903.
129. Schatz C., Viton C., Delair T., Pichot C., Domard A. Typical physicochemical behaviors of chitosan in aqueous solution. Biomacromolecules 2003, 4:641-648.
130. Sorlier P., Rochas C., Morfin I., Viton C., Domard A. Light scattering studies of the solution properties of chitosans of varying degrees of acetylation. Biomacromolecules 2003, 4:1034-1040.
131. Lamarque G., Lucas J.-M., Viton C., Domard A. Physicochemical behavior of homogeneous series of acetylated chitosans in aqueous solution: role of various structural parameters. Biomacromolecules 2005, 6:131-142.
132. Yanagisawa M., Kato Y., Yoshida Y., Isogai A. SEC-MALS study on aggregates of chitosan molecules in aqueous solvents: influence of residual N-acetyl groups. Carbohydr. Polym. 2006, 66:192-198.
133. Christensen B.E., Vold I.M.N., Vårum K.M. Chain stiffness and extension of chitosans and periodate oxidised chitosans studied by size-exclusion chromatography combined with light scattering and viscosity detectors. Carbohydr. Polym. 2008, 74:559-565.
134. Nguyen S., Winnik F.M., Buschmann M.D. Improved reproducibility in the determination of the molecular weight of chitosan by analytical size exclusion chromatography. Carbohydr. Polym. 2009, 75:528-533.
135. Brugnerotto J., Desbrières J., Roberts G., Rinaudo M. Characterization of chitosan by steric exclusion chromatography. Polymer 2001, 42:9921-9927.
136. Anthonsen M.W., Varum K.M., Hermansson A.M., Smidsrod O., Brant D.A. Aggregates in acidic solutions of chitosans detected by static laser light scattering. Carbohydr. Polym. 1994, 25:13-23.
137. Popa-Nita S., Alcouffe P., Rochas C., David L., Domard A. Continuum of structural organization from chitosan solutions to derived physical forms. Biomacromolecules 2009, 11:6-12.
138. Brugnerotto J., Lizardi J., Goycoolea F.M., Argüelles-Monal W., Desbrières J., Rinaudo M. An infrared investigation in relation with chitin and chitosan characterization. Polymer 2001, 42:3569-3580.
139. Domard A., Piron E. Recent approach of metal binding by chitosan and derivatives. Adv. Chitin Sci. 2000, 4:295-301.
140. Zavodinsky V.G., Gnidenko A.A., Davidova V.N., Yermak I.M. Computer simulation of the interaction of bacterial endotoxin with polycation-chitozan, chemistry and computational simulation. Butlerov Commun. 2003, 4:11-12.
141. S. Baker, W.P. Wiesmann, Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials, US Pat. US20080248508A1.
142. S. Baker, W.P. Wiesmann, R. Shannon, A chitosan product having an ultra-low endotoxin concentration and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials, US Pat. US8119780B2.
143. Pillai C.K.S., Paul W., Sharma C.P. Chitin and chitosan polymers: chemistry, solubility and fiber formation. Prog. Polym. Sci. 2009, 34:641-678.
144. K. Kiehm, B. Hauptmeier, P. Boderke, Chitosan beads and filler comprising such beads for cosmetic and medical applications, WO Pat. WO2011124380A1.
145. Polnok A., Borchard G., Verhoef J.C., Sarisuta N., Junginger H.E. Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur. J. Pharm. Biopharm. 2004, 57:77-83.
146. Rinaudo M., Dung P.L., Gey C., Milas M. Substituent distribution on O, N-carboxymethylchitosans by 1H and 13C n.m.r. Int. J. Biol. Macromol. 1992, 14:122-128.
147. Tiera M.J., Qiu X.-P., Bechaouch S., Shi Q., Fernandes J.C., Winnik F.M. Synthesis and characterization of phosphorylcholine-substituted chitosans soluble in physiological pH conditions. Biomacromolecules 2006, 7:3151-3156.
148. Casé A.H., Picola I.P.D., Zaniquelli M.E.D., Fernandes J.C., Taboga S.R., Winnik F.M., Tiera M.J. Physicochemical characterization of nanoparticles formed between DNA and phosphorylcholine substituted chitosans. J. Colloid Interface Sci. 2009, 336:125-133.
149. Malmo J., Varum K.M., Strand S.P. Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans. Biomacromolecules 2011, 12:721-729.
150. Strand S.P., Issa M.M., Christensen B.E., Varum K.M., Artursson P. Tailoring of chitosans for gene delivery: novel self-branched glycosylated chitosan oligomers with improved functional properties. Biomacromolecules 2008, 9:3268-3276.
151. Germershaus O., Mao S., Sitterberg J., Bakowsky U., Kissel T. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. J. Control. Release 2008, 125:145-154.
152. Morris V.B., Sharma C.P. Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality. J. Colloid Interface Sci. 2010, 348:360-368.
153. Park I.K., Park Y.H., Shin B.A., Choi E.S., Kim Y.R., Akaike T., Cho C.S. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier. J. Control. Release 2000, 69:97-108.
154. Morris V.B., Sharma C.P. Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector. Int. J. Pharm. 2010, 389:176-185.
155. Park I.K., Kim T.H., Park Y.H., Shin B.A., Choi E.S., Chowdhury E.H., Akaike T., Cho C.S. Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier. J. Control. Release 2001, 76:349-362.
156. Jeong Y.-I., Kim D.-G., Jang M.-K., Nah J.-W. Preparation and spectroscopic characterization of methoxy poly(ethylene glycol)-grafted water-soluble chitosan. Carbohydr. Res. 2008, 343:282-289.
157. Jiang H.-L., Kwon J.-T., Kim E.-M., Kim Y.-K., Arote R., Jere D., Jeong H.-J., Jang M.-K., Nah J.-W., Xu C.-X., Park I.-K., Cho M.-H., Cho C.-S. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. J. Control. Release 2008, 131:150-157.
158. Satoh T., Nagasaki T., Sakairi N., Shinkai S. 6-Amino-6-deoxychitosan. Preparation and application as plasmid vector in COS-1 cells. Chem. Lett. 2004, 33:340-341.
159. Satoh T., Kano H., Nakatani M., Sakairi N., Shinkai S., Nagasaki T. 6-Amino-6-deoxy-chitosan. Sequential chemical modifications at the C-6 positions of N-phthaloyl-chitosan and evaluation as a gene carrier. Carbohydr. Res. 2006, 341:2406-2413.
160. Strand S.P., Lelu S., Reitan N.K., Davies C.D., Artursson P., Varum K.M. Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking. Biomaterials 2010, 31:975-987.
161. Tømmeraas K., Strand S.P., Christensen B.E., Smidsrød O., Vårum K.M. Preparation and characterization of branched chitosans. Carbohydr. Polym. 2011, 83:1558-1564.
162. Gao S., Chen J., Xu X., Ding Z., Yang Y.-H., Hua Z., Zhang J. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int. J. Pharm. 2003, 255:57-68.
163. Jiang H.L., Kwon J.T., Kim Y.K., Kim E.M., Arote R., Jeong H.J., Nah J.W., Choi Y.J., Akaike T., Cho M.H., Cho C.S. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. Gene Ther. 2007, 14:1389-1398.
164. Satoh T., Kakimoto S., Kano H., Nakatani M., Shinkai S., Nagasaki T. In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier. Carbohydr. Res. 2007, 342:1427-1433.
165. Kim T.H., Ihm J.E., Choi Y.J., Nah J.W., Cho C.S. Efficient gene delivery by urocanic acid-modified chitosan. J. Control. Release 2003, 93:389-402.
166. Moreira C., Oliveira H., Pires L.R., Simoes S., Barbosa M.A., Pego A.P. Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone. Acta Biomater. 2009, 5:2995-3006.
167. Jiang H.L., Kim Y.K., Arote R., Nah J.W., Cho M.H., Choi Y.J., Akaike T., Cho C.S. Chitosan-graft-polyethylenimine as a gene carrier. J. Control. Release 2007, 117:273-280.
168. Wong K., Sun G. Zhang, H. Dai, Y. Liu, He, K.W. Leong, PEI-g-chitosan, a Novel Gene Delivery System with Transfection Efficiency Comparable to Polyethylenimine in Vitro and after Liver Administration in Vivo. Bioconjugate Chem. 2005, 17:152-158.
169. Lu B., Xu X.D., Zhang X.Z., Cheng S.X., Zhuo R.X. Low molecular weight polyethylenimine grafted N-maleated chitosan for gene delivery: properties and in vitro transfection studies. Biomacromolecules 2008, 9:2594-2600.
170. Lu B., Sun Y.-X., Li Y.-Q., Zhang X.-Z., Zhuo R.-X. N-Succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector. Mol. Biosyst. 2009, 5:629-637.
171. Chang K.L., Higuchi Y., Kawakami S., Yamashita F., Hashida M. Development of lysine-histidine dendron modified chitosan for improving transfection efficiency in HEK293 cells. J. Control. Release 2011, 156:195-202.
172. Xu Z., Wan X., Zhang W., Wang Z., Peng R., Tao F., Cai L., Li Y., Jiang Q., Gao R. Synthesis of biodegradable polycationic methoxy poly(ethylene glycol)-polyethylenimine-chitosan and its potential as gene carrier. Carbohydr. Polym. 2009, 78:46-53.
173. Griffiths P.R., de Haseth J.A. Fourier Transform Infrared Spectroscopy 2007, John Wiley & Sons, Inc., Hoboken, NJ.
174. Darras V., Nelea M., Winnik F.M., Buschmann M.D. Chitosan modified with gadolinium diethylenetriaminepentaacetic acid for magnetic resonance imaging of DNA/chitosan nanoparticles. Carbohydr. Polym. 2010, 80:1137-1146.
175. Tharanathan R.N., Kittur F.S. Chitin - the undisputed biomolecule of great potential. Crit. Rev. Food Sci. Nutr. 2003, 43:61-87.
176. Sieval A.B., Thanou M., KotzeD́ A.F., Verhoef J.C., Brussee J., Junginger H.E. Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride. Carbohydr. Polym. 1998, 36:157-165.
177. Florea B.I., Thanou M., Geldof M., Meaney C., Junginger H.E., Borchard G. Modified chitosan oligosaccharides as transfection agents for gene therapy in cystic fibrosis. Proc. Int. Symp. Controlled Release Bioact. Mater., 27th 2000, 846-847.
178. Snyman D., Hamman J.H., Kotze J.S., Rollings J.E., Kotzé A.F. The relationship between the absolute molecular weight and the degree of quaternisation of N-trimethyl chitosan chloride. Carbohydr. Polym. 2002, 50:145-150.
179. Thanou M., Florea B.I., Geldof M., Junginger H.E., Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 2002, 23:153-159.
180. Kean T., Roth S., Thanou M. Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J. Control. Release 2005, 103:643-653.
181. Loubaki E., Ourevitch M., Sicsic S. Chemical modification of chitosan by glycidyl trimethylammonium chloride. characterization of modified chitosan by 13C- and 1H-NMR spectroscopy. Eur. Polym. J. 1991, 27:311-317.
182. Kim C.-H., Kim S.-Y., Choi K.-S. Synthesis and antibacterial activity of water-soluble chitin derivatives. Polym. Adv. Technol. 1997, 8:319-325.
183. Faizuloev E., Marova A., Nikonova A., Volkova I., Gorshkova M., Izumrudov V. Water-soluble N-[(2-hydroxy-3-trimethylammonium)propyl]chitosan chloride as a nucleic acids vector for cell transfection. Carbohydr. Polym. 2012, 89:1088-1094.
184. Hermanson G.T. Bioconjugate Techniques 2008, Academic Press, Amsterdam.
185. Lee J.I., Ha K.-S., Yoo H.S. Quantum-dot-assisted fluorescence resonance energy transfer approach for intracellular trafficking of chitosan/DNA complex. Acta Biomater. 2008, 4:791-798.
186. Tømmeraas K., Strand S.P., Tian W., Kenne L., Vårum K.M. Preparation and characterisation of fluorescent chitosans using 9-anthraldehyde as fluorophore. Carbohydr. Res. 2001, 336:291-296.
187. Vold I.M.N., Christensen B.E. Periodate oxidation of chitosans with different chemical compositions. Carbohydr. Res. 2005, 340:679-684.
188. Ma O., Lavertu M., Sun J., Nguyen S., Buschmann M.D., Winnik F.M., Hoemann C.D. Precise derivatization of structurally distinct chitosans with rhodamine B isothiocyanate. Carbohydr. Polym. 2008, 72:616-624.
189. Nishimura S., Kohgo O., Kurita K., Kuzuhara H. Chemospecific manipulations of a rigid polysaccharide: syntheses of novel chitosan derivatives with excellent solubility in common organic solvents by regioselective chemical modifications. Macromolecules 1991, 24:4745-4748.
190. Kurita K., Ikeda H., Yoshida Y., Shimojoh M., Harata M. Chemoselective protection of the amino groups of chitosan by controlled phthaloylation: facile preparation of a precursor useful for chemical modifications. Biomacromolecules 2001, 3:1-4.
191. Cai G., Jiang H., Tu K., Wang L., Zhu K. A facile route for regioselective conjugation of organo-soluble polymers onto chitosan. Macromol. Biosci. 2009, 9:256-261.
192. M. Lavertu, S. Methot, M.D. Buschmann, Composition and Method for Efficient Delivery of Nucleic Acids to Cells Using Chitosan, Pat. WO2007059605-A1; EP1948810-A1; US2009075383-A1; CA2628313-A1.
193. Klausner E.A., Zhang Z., Chapman R.L., Multack R.F., Volin M.V. Ultrapure chitosan oligomers as carriers for corneal gene transfer. Biomaterials 2010, 31:1814-1820.
194. Dautzenberg H., Jaeger W. Effect of charge density on the formation and salt stability of polyelectrolyte complexes. Macromol. Chem. Phys. 2002, 203:2095-2102.
195. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:7413-7417.
196. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 1987, 262:4429-4432.
197. Kabanov V.A., Zezin A.B. A new class of complex water-soluble polyelectrolytes. Macromol. Chem. Phys. Suppl. 1984, 6:259-276.
198. Kabanov A.V., Kabanov V.A. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjugate Chem. 1995, 6:7-20.
199. Philipp B., Dautzenberg H., Linow K.J., Koetz J., Dawydoff W. Polyelectrolyte complexes - recent developments and open problems. Prog. Polym. Sci. 1989, 14:91-172.
200. Dautzenberg H. Polyelectrolyte complex formation in highly aggregating systems. 1. Effect of salt: Polyelectrolyte complex formation in the presence of NaCl. Macromolecules 1997, 30:7810-7815.
201. Dautzenberg H., Hartmann J., Grunewald S., Brand F. Stoichiometry and structure of polyelectrolyte complex particles in diluted solutions. Ber. Bunsen-Ges. Phys. Chem. Chem. Phys. 1996, 100:1024-1032.
202. Thuenemann A.F., Mueller M., Dautzenberg H., Joanny J.-F., Loewen H. Polyelectrolyte complexes. Adv. Polym. Sci. 2004, 166:113-171.
203. Tsuchida E., Osada Y., Sanada K. Interaction of poly(styrene sulfonate) with polycations carrying charges in the chain backbone. J. Polym. Sci., Part A-1 1972, 10:3397-3404.
204. Rungsardthong U., Ehtezazi T., Bailey L., Armes S.P., Garnett M.C., Stolnik S. Effect of polymer ionization on the interaction with DNA in nonviral gene delivery systems. Biomacromolecules 2003, 4:683-690.
205. Danielsen S., Varum K.M., Stokke B.T. Structural analysis of chitosan mediated DNA condensation by AFM: Influence of chitosan molecular parameters. Biomacromolecules 2004, 5:928-936.
206. Oupicky D., Konak C., Ulbrich K., Wolfert M.A., Seymour L.W. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J. Control. Release 2000, 65:149-171.
207. Schatz C., Domard A., Viton C., Pichot C., Delair T. Versatile and efficient formation of colloids of biopolymer-based polyelectrolyte complexes. Biomacromolecules 2004, 5:1882-1892.
208. MacLaughlin F.C., Mumper R.J., Wang J., Tagliaferri J.M., Gill I., Hinchcliffe M., Rolland A.P. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release 1998, 56:259-272.
209. Jean M., Alameh M., De Jesus D., Thibault M., Lavertu M., Darras V., Nelea M., Buschmann M.D., Merzouki A. Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes. Eur. J. Pharm. Sci. 2012, 45:138-149.
210. Howard K.A., Paludan S.R., Behlke M.A., Besenbacher F., Deleuran B., Kjems J. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol. Ther. 2009, 17:162-168.
211. Katas H., Alpar H.O. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release 2006, 115:216-225.
212. Gaspar V.M., Sousa F., Queiroz J.A., Correia I.J. Formulation of chitosan-TPP-pDNA nanocapsules for gene therapy applications. Nanotechnology 2011, 22.
213. Csaba N., Koping-Hoggard M., Alonso M.J. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm. 2009, 382:205-214.
214. Ravina M., Cubillo E., Olmeda D., Novoa-Carballal R., Fernandez-Megia E., Riguera R., Sanchez A., Cano A., Alonso M.J. Hyaluronic Acid/Chitosan-g-Poly(ethylene glycol) Nanoparticles for Gene Therapy: An Application for pDNA and siRNA Delivery. Pharm. Res. 2010, 27:2544-2555.
215. Zeng P., Xu Y., Zeng C.H., Ren H., Peng M.L. Chitosan-modified poly(D, L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int. J. Pharm. 2011, 415:259-266.
216. Kumar M., Bakowsky U., Lehr C.M. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004, 25:1771-1777.
217. Lee K.Y., Kwon I.C., Kim Y.H., Jo W.H., Jeong S.Y. Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Release 1998, 51:213-220.
218. Kim Y.H., Gihm S.H., Park C.R., Lee K.Y., Kim T.W., Kwon I.C., Chung H., Jeong S.Y. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjugate Chem. 2001, 12:932-938.
219. Huang M., Fong C.W., Khor E., Lim L.Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J. Control. Release 2005, 106:391-406.
220. Koping-Hoggard M., Tubulekas I., Guan H., Edwards K., Nilsson M., Varum K.M., Artursson P. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 2001, 8:1108-1121.
221. Nielsen E.J.B., Nielsen J.M., Becker D., Karlas A., Prakash H., Glud S.Z., Merrison J., Besenbacher F., Meyer T.F., Kjems J., Howard K.A. Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles. Pharm. Res. 2010, 27:2520-2527.
222. Sato T., Ishii T., Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001, 22:2075-2080.
223. Huang H.N., Li T.L., Chan Y.L., Chen C.L., Wu C.J. Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus. Biomaterials 2009, 30:6017-6025.
224. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release 1998, 53:183-193.
225. Romoren K., Pedersen S., Smistad G., Evensen O., Thu B.J. The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes. Int. J. Pharm. 2003, 261:115-127.
226. Holzerny P., Ajdini B., Heusermann W., Bruno K., Schuleit M., Meinel L., Keller M. Biophysical properties of chitosan/siRNA polyplexes: Profiling the polymer/siRNA interactions and bioactivity. J. Control. Release 2012, 157:297-304.
227. Erbacher P., Zou S., Bettinger T., Steffan A.M., Remy J.S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 1998, 15:1332-1339.
228. Liu W.G., Sun S.J., Cao Z.Q., Xin Z., Yao K.D., Lu W.W., Luk K.D.K. An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials 2005, 26:2705-2711.
229. Ma P.L., Buschmann M.D., Winnik F.M. Complete physicochemical characterization of DNA/chitosan complexes by multiple detection using asymmetrical flow field-flow fractionation. Anal. Chem. 2010, 82:9636-9643.
230. Ma P.L., Buschmann M.D., Winnik F.M. One-step analysis of DNA/chitosan complexes by field-flow fractionation reveals particle size and free chitosan content. Biomacromolecules 2010, 11:549-554.
231. Xu L., Anchordoquy T. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J. Pharm. Sci. 2011, 100:38-52.
232. Bakeev K.N., Izumrudov V.A., Zezin A.B., Kabanov V.A. Kinetics and mechanism of the formation of polyelectrolyte complexes. Dokl. Akad. Nauk SSSR 1988, 299:1405-1408.
233. Kasper J.C., Schaffert D., Ogris M., Wagner E., Friess W. The establishment of an up-scaled micro-mixer method allows the standardized and reproducible preparation of well-defined plasmid/LPEI polyplexes. Eur. J. Pharm. Biopharm. 2011, 77:182-185.
234. Davies L.A., Nunez-Alonso G.A., Hebel H.L., Scheule R.K., Cheng S.H., Hyde S.C., Gill D.R. A novel mixing device for the reproducible generation of nonviral gene therapy formulations. Biotechniques 2010, 49:666-668.
235. Jean M., Alameh M., Buschmann M.D., Merzouki A. Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes. Gene Ther. 2011, 18:807-816.
236. Ankerfors C., Ondaral S., Wagberg L., Odberg L. Using jet mixing to prepare polyelectrolyte complexes: Complex properties and their interaction with silicon oxide surfaces. J. Colloid Interface Sci. 2010, 351:88-95.
237. Anchordoquy T.J., Armstrong T.K., Molina M.D. Low molecular weight dextrans stabilize nonviral vectors during lyophilization at low osmolalities: concentrating suspensions by rehydration to reduced volumes. J. Pharm. Sci. 2005, 94:1226-1236.
238. Miyata K., Kakizawa Y., Nishiyama N., Yamasaki Y., Watanabe T., Kohara M., Kataoka K. Freeze-dried formulations for in vivo gene delivery of PEGylated polyplex micelles with disulfide crosslinked cores to the liver. J. Control. Release 2005, 109:15-23.
239. Cherng J.Y., Talsma H., Crommelin D.J., Hennink W.E. Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems. Pharm. Res. 1999, 16:1417-1423.
240. Andersen M.O., Howard K.A., Paludan S.R., Besenbacher F., Kjems J. Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials 2008, 29:506-512.
241. Kuriyel R., Fushijima M., Jung G.W. Advancements in membrane processes for pharmaceutical applications 2009, 409-426. CRC Press.
242. Dalwadi G., Sunderland V.B. Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev. Ind. Pharm. 2007, 33:1030-1039.
243. Dalwadi G., Benson H.A.E., Chen Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions. Pharm. Res. 2005, 22:2152-2162.
244. Trefry J.C., Monahan J.L., Weaver K.M., Meyerhoefer A.J., Markopolous M.M., Arnold Z.S., Wooley D.P., Pavel I.E. Size selection and concentration of silver nanoparticles by tangential flow ultrafiltration for SERS-based biosensors. J. Am. Chem. Soc. 2010, 132:10970-10972.
245. Limayem I., Charcosset C., Fessi H. Purification of nanoparticle suspensions by a concentration/diafiltration process. Sep. Purif. Technol. 2004, 38:1-9.
246. Mumper R.J., Wang J., Claspell J.M., Rolland A.P. Novel polymeric condensing carriers for gene delivery. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 1995, 22:178-179.
247. Prabha S., Zhou W.Z., Panyam J., Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. 2002, 244:105-115.
248. Kabanov A.V. Taking polycation gene delivery systems from in vitro to in vivo. Pharm. Sci. Technol. Today 1999, 2:365-372.
249. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14265-14270.
250. Bowman K., Sarkar R., Raut S., Leong K.W. Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles. J. Control. Release 2008, 132:252-259.
251. Lou Y.L., Peng Y.S., Chen B.H., Wang L.F., Leong K.W. Poly(ethylene imine)-g-chitosan using EX-810 as a spacer for nonviral gene delivery vectors. J. Biomed. Mater. Res. Part A 2009, 88A:1058-1068.
252. Filipe V., Hawe A., Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm. Res. 2010, 27:796-810.
253. Koping-Hoggard M., Mel'nikova Y.S., Varum K.M., Lindman B., Artursson P. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. Journal of Gene Medicine 2003, 5:130-141.
254. Mittnacht U., Hartmann H., Hein S., Oliveira H., Dong M., Pego A.P., Kjems J., Howard K.A., Schlosshauer B. Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth. Nano Lett. 2010, 10:3933-3939.
255. Liu X., Howard K.A., Dong M., Andersen M.O., Rahbek U.L., Johnsen M.G., Hansen O.C., Besenbacher F., Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007, 28:1280-1288.
256. Ma P.L., Lavertu M., Winnik F.M., Buschmann M.D. New insights into chitosan-DNA interactions using isothermal titration microcalorimetry. Biomacromolecules 2009, 10:1490-1499.
257. Noh S.M., Park M.O., Shim G., Han S.E., Lee H.Y., Huh J.H., Kim M.S., Choi J.J., Kim K., Kwon I.C., Kim J.S., Baek K.H., Oh Y.K. Pegylated poly-L-arginine derivatives of chitosan for effective delivery of siRNA. J. Control. Release 2010, 145:159-164.
258. Khai-Woon E., Chen H.Y., Lo Y.L., Huang S.J., Wang L.F. Succinated chitosan as a gene carrier for improved chitosan solubility and gene transfection. Nanomed. Nanotechnol. Biol. Med. 2011, 7:174-183.
259. Thibault M., Nimesh S., Lavertu M., Buschmann M.D. Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes. Mol. Ther. 2010, 18:1787-1795.
260. Nimesh S., Thibault M.M., Lavertu M., Buschmann M.D. Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum. Mol. Biotechnol. 2010, 46:182-196.
261. Erbacher P., Roche A.C., Monsigny M., Midoux P. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA lactosylated polylysine complexes. Exp. Cell Res. 1996, 225:186-194.
262. Corsi K., Chellat F., Yahia L., Fernandes J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003, 24:1255-1264.
263. Noguchi H., Yoshikawa K. Morphological variation in a collapsed single homopolymer chain. J. Chem. Phys. 1998, 109:5070-5077.
264. Lu H.D., Zhao H.Q., Wang K., Lv L.L. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Int. J. Pharm. 2011, 420:358-365.
265. Lu B., Wang C.F., Wu D.Q., Li C., Zhang X.Z., Zhuo R.X. Chitosan based oligoamine polymers: synthesis, characterization, and gene delivery. J. Control. Release 2009, 137:54-62.
266. Li Z.T., Guo J., Zhang J.S., Zhao Y.P., Lv L., Ding C., Zhang X.Z. Chitosan-graft-polyethylenimine with improved properties as a potential gene vector. Carbohydr. Polym. 2010, 80:254-259.
267. Ping Y., Liu C., Zhang Z., Liu K.L., Chen J., Li J. Chitosan-graft-(PEI-beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials 2011, 32:8328-8341.
268. Bloomfield V.A. Condensation of DNA by multivalent cations: considerations on mechanism. Biopolymers 1991, 31:1471-1481.
269. Lee D.W., Yun K.S., Ban H.S., Choe W., Lee S.K., Lee K.Y. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. J. Control. Release 2009, 139:146-152.
270. Dehousse V., Garbacki N., Jaspart S., Castagne D., Piel G., Colige A., Evrard B. Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. Int. J. Biol. Macromol. 2010, 46:342-349.
271. Katas H., Somavarapu S., Alpar H.O. Nanocarriers for siRNA based on cationic polymers: chitosan and TAT peptide. J. Pharm. Pharmacol. 2005, 57:S54.
272. Alameh M., DeJesus D., Jean M., Darras V., Thibault M., Lavertu M., Buschmann M.D., Merzouki A. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. Int. J. Nanomed. 2012, 7:1399-1414.
273. Wahlund K.G., Giddings J.C. Properties of an asymmetrical flow field-flow fractionation channel having one permeable wall. Anal. Chem. 1987, 59:1332-1339.
274. Schimpf M. Field Flow Fractionation Handbook 2000.
275. Richard I., Thibault M., De Crescenzo G., Buschmann M.D., Lavertu M. Ionization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI. Biomacromolecules 2013, 14:1732-1740.
276. Jiang X., Dai H., Leong K.W., Goh S.H., Mao H.Q., Yang Y.Y. Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions. J. Gene Med. 2006, 8:477-487.
277. Li C.X., Guo T.Y., Zhou D.Z., Hu Y.L., Zhou H., Wang S.F., Chen J.T., Zhang Z.P. A novel glutathione modified chitosan conjugate for efficient gene delivery. J. Control. Release 2011, 154:177-188.
278. Yu Y.Y., Wang Z., Cai L., Wang G., Yang X., Wan X.P., Xu X.H., Li Y., Gao R. Synthesis and characterization of methoxy poly(ethylene glycol)-O-chitosan-polyethylenimine for gene delivery. Carbohydr. Polym. 2010, 81:269-274.
279. Zhao X., Yin L.C., Ding J.Y., Tang C., Gu S.H., Yin C.H., Mao Y.M. Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. J. Control. Release 2010, 144:46-54.
280. Lee S.J., Huh M.S., Lee S.Y., Min S., Lee S., Koo H., Chu J.U., Lee K.E., Jeon H., Choi Y., Choi K., Byun Y., Jeong S.Y., Park K., Kim K., Kwon I.C. Tumor-Homing Poly-siRNA/Glycol Chitosan Self-Cross-Linked Nanoparticles for Systemic siRNA Delivery in Cancer Treatment. Angew Chem. Int. Ed. Engl. 2012, 51:7203-7207.
281. Ogris M., Brunner S., Schuller S., Kircheis R., Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999, 6:595-605.
282. Albanese A., Tang P.S., Chan W.C.W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 2012, 14:1-16.
283. Elsabahy M., Wooley K.L. Design of polymeric nanoparticles for biomedical delivery applications. Chem. Soc. Rev. 2012, 41:2545-2561.
284. Allen C., Dos Santos N., Gallagher R., Chiu G.N.C., Shu Y., Li W.M., Johnstone S.A., Janoff A.S., Mayer L.D., Webb M.S., Bally M.B. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci. Rep. 2002, 22:225-250.
285. Allen T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 1994, 15:215-220.
286. Zhang Y.Q., Chen J.J., Zhang Y.D., Pan Y.F., Zhao J.F., Ren L.F., Liao M.M., Hu Z.Y., Kong L., Wang J.W. A novel PEGylation of chitosan nanoparticles for gene delivery. Biotechnol. Appl. Biochem. 2007, 46:197-204.
287. Merdan T., Kunath K., Petersen H., Bakowsky U., Voigt K.H., Kopecek J., Kissel T. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconjugate Chem. 2005, 16:785-792.
288. Lai E., van Zanten J.H. Monitoring DNA/poly-L-lysine polyplex formation with time-resolved multiangle laser light scattering. Biophys. J. 2001, 80:864-873.
289. Welsh S., Kay S.A. Reporter gene expression for monitoring gene transfer. Curr. Opin. Biotechnol. 1997, 8:617-622.
290. Caceres G., Xiao Y.Z.U., Jiao J.A., Zankina R., Aller A., Andreotti P. Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence 2003, 18:218-223.
291. R. Varma, S. Magdaleno, Appropriate positive and negative controls are always important in biological experiments, Life Technologies application note.
292. Venkatesh S., Smith T.J. Chitosan-membrane interactions and their probable role in chitosan-mediated transfection. Biotechnol. Appl. Biochem. 1998, 27:265-267.
293. Koping-Hoggard M., Nilsson M., Edwards K., Artursson P. Chitosan-DNA polyplex: a new efficient, biodegradable gene delivery system. Proc. Int'l. Symp. Control. Rel. Bioact. Mater. 1998, 25:368-369.
294. Kiang T., Bright C., Cheung C.Y., Stayton P.S., Hoffman A.S., Leong K.W. Formulation of chitosan-DNA nanoparticles with poly(propyl acrylic acid) enhances gene expression. J. Biomater. Sci. Polym. Ed. 2004, 15:1405-1421.
295. Douglas K.L., Piecirillo C.A., Tabrizian M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J. Control. Release 2006, 115:354-361.
296. Thibault M., Astolfi M., Tran-Khanh N., Lavertu M., Darras V., Merzouki A., Buschmann M.D. Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes. Biomaterials 2011, 32:4639-4646.
297. Nanosight, visualisation, sizing and counting of fluorescent and fluorescently-labelled nanoparticles. Application Note 2010.
298. Braeckmans K., Buyens K., Bouquet W., Vervaet C., Joye P., De Vos F., Plawinski L., Doeuvre L., Angles-Cano E., Sanders N.N., Demeester J., De Smedt S.C. Sizing Nanomatter in Biological Fluids by Fluorescence Single Particle Tracking. Nano Lett. 2010, 10:4435-4442.
299. van Gaal E.V.B., Spierenburg G., Hennink W.E., Crommelin D.J.A., Mastrobattista E. Flow cytometry for rapid size determination and sorting of nucleic acid containing nanoparticles in biological fluids. J. Control. Release 2010, 141:328-338.
300. Park I.K., Ihm J.E., Park Y.H., Choi Y.J., Kim S.I., Kim W.J., Akaike T., Cho C.S. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier. Preparation and physicochemical characterization of GC-graft-PVP/DNA complex (1). J Control Release 2003, 86:349-359.
301. Bieber T., Meissner W., Kostin S., Niemann A., Elsasser H.P. Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J. Control. Release 2002, 82:441-454.
302. Peng S.F., Tseng M.T., Ho Y.C., Wei M.C., Liao Z.X., Sung H.W. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(gamma-glutamic acid) complexes as a gene delivery vector. Biomaterials 2011, 32:239-248.
303. Jones N.A., Hill I.R.C., Stolnik S., Bignotti F., Davis S.S., Garnett M.C. Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery. Biochim. Biophys. Acta-Gene Struct. Expression 2000, 1517:1-18.
304. Rojanarata T., Opanasopit P., Techaarpornkul S., Ngawhirunpat T., Ruktanonchai U. Chitosan-Thiamine Pyrophosphate as a Novel Carrier for siRNA Delivery. Pharm. Res. 2008, 25:2807-2814.
305. Wedmore I., McManus J.G., Pusateri A.E., Holcomb J.B. A special report on the chitosan-based hemostatic dressing: Experience in current combat operations. J. Trauma-Injury Infect. Crit. Care 2006, 60:655-658.
306. Varum K.M., Myhr M.M., Hjerde R.J.N., Smidsrod O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res. 1997, 299:99-101.
307. Boot R.G., Renkema G.H., Strijland A., van Zonneveld A.J., Aerts J.M. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J. Biol. Chem. 1995, 270:26252-26256.
308. Muzzarelli R.A.A. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell. Mol. Life Sci. 1997, 53:131-140.
309. Huang M., Khor E., Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm. Res. 2004, 21:344-353.
310. Schipper N.G.M., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs.1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res. 1996, 13:1686-1692.
311. Gorzelanny C., Poeppelmann B., Pappelbaum K., Moerschbacher B.M., Schneider S.W. Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation. Biomaterials 2010, 31:8556-8563.
312. Guzman-Morales J., Ariganello M.B., Hammami I., Thibault M., Jolicoeur M., Hoemann C.D. Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages. Biochem. Biophys. Res. Commun. 2011, 405:538-544.
313. Fotakis G., Timbrell J.A. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 2006, 160:171-177.
314. Kai E., Ochiya T. A method for oral DNA delivery with N-acetylated chitosan. Pharm. Res. 2004, 21:838-843.
315. Douglas K.L., Piccirillo C.A., Tabrizian M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur. J. Pharm. Biopharm. 2008, 68:676-687.
316. Turan K., Nagata K. Chitosan-DNA nanoparticles: the effect of cell type and hydrolysis of chitosan on in vitro DNA transfection. Pharm. Dev. Technol. 2006, 11:503-512.
317. Brunner S., Furtbauer E., Sauer T., Kursa M., Wagner E. Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther. 2002, 5:80-86.
318. Won Y.Y., Sharma R., Konieczny S.F. Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes. J. Control. Release 2009, 139:88-93.
319. Sonawane N.D., Szoka F.C., Verkman A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 2003, 278:44826-44831.
320. Chen H.H., Ho Y.P., Jiang X., Mao H.Q., Wang T.H., Leong K.W. Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum Dot-FRET. Mol. Ther. 2008, 16:324-332.
321. Kiang T., Wen H., Lim H.W., Leong K.W. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 2004, 25:5293-5301.
322. Steen M., Kirchberger T., Guse A.H. NAADP mobilizes calcium from the endoplasmic reticular Ca2+ store in T-lymphocytes. J. Biol. Chem. 2007, 282:18864-18871.
323. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene Med. 2004, 6:76-84.
324. Kichler A., Leborgne C., Coeytaux E., Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene Med. 2001, 3:135-144.
325. Behr J.P. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 1997, 51:34-36.
326. Bowman K., Leong K.W. Chitosan nanoparticles for oral drug and gene delivery. Int. J. Nanomed. 2006, 1:117-128.
327. Forrest M.L., Gabrielson N., Pack D.W. Reduction of polyethylenimine buffering capacity enhances in-vitro gene delivery activity. Mol. Ther. 2004, 9:S138.
328. Gabrielson N.P., Pack D.W. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules 2006, 7:2427-2435.
329. Godbey W.T., Barry M.A., Saggau P., Wu K.K., Mikos A.G. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J. Biomed. Mater. Res. 2000, 51:321-328.
330. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 2001, 22:471-480.
331. Kim T.H., Kim S.I., Akaike T., Cho C.S. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J. Control. Release 2005, 105:354-366.
332. Schaffer D.V., Fidelman N.A., Dan N., Lauffenburger D.A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 2000, 67:598-606.
333. Ho Y.P., Chen H.H., Leong K.W., Wang T.H. Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J. Control. Release 2006, 116:83-89.
334. LabatMoleur F., Steffan A.M., Brisson C., Perron H., Feugeas O., Furstenberger P., Oberling F., Brambilla E., Behr J.P. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. 1996, 3:1010-1017.
335. Liang D.C., Liu W.G., Zuo A.J., Sun S.J., Cheng N., Guo G., Zhang J.Y., De Yao K. Pre-deliver chitosanase to cells: a novel strategy to improve gene expression by endocellular degradation-induced vector unpacking. Int. J. Pharm. 2006, 314:63-71.
336. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2003, 348:255-256.
337. Check E. A tragic setback. Nature 2002, 420:116-118.
338. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application, and optimization*. Annu. Rev. Immunol. 2000, 18:927-974.
339. Dodane V., Amin Khan M., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 1999, 182:21-32.
340. McNeela E.A., O'Connor D., Jabbal-Gill I., Illum L., Davis S.S., Pizza M., Peppoloni S., Rappuoli R., Mills K.H. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine 2000, 19:1188-1198.
341. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 1999, 5:387-391.
342. Khatri K., Goyal A.K., Gupta P.N., Mishra N., Vyas S.P. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int. J. Pharm. 2008, 354:235-241.
343. Schirmbeck R., Reimann J. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen. Biol. Chem. 2001, 382:543-552.
344. Bramwell V.W., Eyles J.E., Somavarapu S., Alpar H.O. Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology 2002, 106:412-418.
345. Bos G.W., Kanellos T., Crommelin D.J., Hennink W.E., Howard C.R. Cationic polymers that enhance the performance of HbsAg DNA in vivo. Vaccine 2004, 23:460-469.
346. Takashima A., Morita A. Dendritic cells in genetic immunization. J. Leukoc. Biol. 1999, 66:350-356.
347. Shedlock D.J., Weiner D.B. DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 2000, 68:793-806.
348. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
349. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today 1994, 15:269-274.
350. Otterlei M., Varum K.M., Ryan L., Espevik T. Characterization of binding and TNF-alpha-inducing ability of chitosans on monocytes: the involvement of CD14. Vaccine 1994, 12:825-832.
351. Chou T.C., Fu E., Shen E.C. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 2003, 308:403-407.
352. Meyer K.B., Thompson M.M., Levy M.Y., Barron L.G., Szoka F.C. Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics. Gene Ther. 1995, 2:450-460.
353. Tuomela M., Malm M., Wallen M., Stanescu I., Krohn K., Peterson P. Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method. Vaccine 2005, 23:890-896.
354. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
355. Bantounas I., Phylactou L.A., Uney J.B. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J. Mol. Endocrinol. 2004, 33:545-557.
356. Castanotto D., Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009, 457:426-433.
357. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., McClintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 2006, 441:111-114.
358. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
359. Whelan J. First clinical data on RNAi. Drug Discovery Today 2005, 10:1014-1015.
360. Corey D.R. Chemical modification: the key to clinical application of RNA interference?. J. Clin. Invest. 2007, 117:3615-3622.
361. Corey D.R. RNA learns from antisense. Nat. Chem. Biol. 2007, 3:8-11.
362. Stein C.A. Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. Trends Biotechnol. 1996, 14:147-149.
363. Urban-Klein B., Werth S., Abuharbeid S., Czubayko F., Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 2005, 12:461-466.
364. Salva E., Kabasakal L., Eren F., Ozkan N., Cakalagaoglu F., Akbuga J. Local delivery of chitosan/VEGF siRNA nanoplexes reduces angiogenesis and growth of breast cancer in vivo. Nucleic Acid Ther. 2012, 22:40-48.
365. Han H.D., Mora E.M., Roh J.W., Nishimura M., Lee S.J., Stone R.L., Bar-Eli M., Lopez-Berestein G., Sood A.K. Chitosan hydrogel for localized gene silencing. Cancer Biol. Ther. 2011, 11:839-845.
366. Kim H.S., Han H.D., Armaiz-Pena G.N., Stone R.L., Nam E.J., Lee J.W., Shahzad M.M., Nick A.M., Lee S.J., Roh J.W., Nishimura M., Mangala L.S., Bottsford-Miller J., Gallick G.E., Lopez-Berestein G., Sood A.K. Functional roles of Src and Fgr in ovarian carcinoma. Clin. Cancer Res. 2011, 17:1713-1721.
367. Wiegand C., Winter D., Hipler U.C. Molecular-weight-dependent toxic effects of chitosans on the human keratinocyte cell line HaCaT. Skin Pharmacol. Physiol. 2010, 23:164-170.
368. Yang Y.M., Hu W., Wang X.D., Gu X.S. The controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivo. J. Mater. Sci. Mater. Med. 2007, 18:2117-2121.
369. Xu J., McCarthy S.P., Gross R.A., Kaplan D.L. Chitosan film acylation and effects on biodegradability. Macromolecules 1996, 29:3436-3440.
370. Hirano S., Tsuchida H., Nagao N. N-acetylation in chitosan and the rate of its enzymic hydrolysis. Biomaterials 1989, 10:574-576.
371. Gao S., Dagnaes-Hansen F., Nielsen E.J., Wengel J., Besenbacher F., Howard K.A., Kjems J. The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice. Mol. Ther. 2009, 17:1225-1233.
372. Yan J., Yang L., Wang G., Xiao Y., Zhang B., Qi N. Biocompatibility evaluation of chitosan-based injectable hydrogels for the culturing mice mesenchymal stem cells in vitro. J. Biomater. Appl. 2010, 24:625-637.
373. Huh M.S., Lee S.Y., Park S., Lee S., Chung H., Choi Y., Oh Y.K., Park J.H., Jeong S.Y., Choi K., Kim K., Kwon I.C. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J. Control. Release 2010, 144:134-143.
374. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46:6387-6392.
375. Yan C., Chen D., Gu J., Qin J. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization-in-vitro drug release and anti-tumour activity. J. Pharm. Pharmacol. 2006, 58:1177-1181.
376. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 2011, 63:131-135.
377. Cheng M., Li Q., Wan T., Hong X., Chen H., He B., Cheng Z., Xu H., Ye T., Zha B., Wu J., Zhou R. Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo. J. Biomed. Mater. Res. B Appl. Biomater. 2011, 99:70-80.
378. Guliyeva U., Oner F., Ozsoy S., Haziroglu R. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur. J. Pharm. Biopharm. 2006, 62:17-25.
379. Li G.P., Liu Z.G., Liao B., Zhong N.S. Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cell. Mol. Immunol. 2009, 6:45-50.
380. Chen J., Yang W.L., Li G., Qian J., Xue J.L., Fu S.K., Lu D.R. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J. Gastroenterol. 2004, 10:112-116.
381. Sun C.J., Pan S.P., Xie Q.X., Xiao L.J. Preparation of chitosan-plasmid DNA nanoparticles encoding zona pellucida glycoprotein-3alpha and its expression in mouse. Mol. Reprod. Dev. 2004, 68:182-188.
382. Zheng F., Shi X.W., Yang G.F., Gong L.L., Yuan H.Y., Cui Y.J., Wang Y., Du Y.M., Li Y. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sci. 2007, 80:388-396.
383. Hejazi R., Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control. Release 2003, 89:151-165.
384. Tian J., Yu J., Sun X. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus). Vet. Immunol. Immunopathol. 2008, 126:220-229.
385. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A.N., Davis S.S. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 2001, 51:81-96.
386. Luo Y., Zhai X., Ma C., Sun P., Fu Z., Liu W., Xu J. An inhalable beta(2)-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung. J. Control. Release. 2012, 162:28-36.
387. Kong X., Zhang W., Lockey R.F., Auais A., Piedimonte G., Mohapatra S.S. Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet Vaccines Ther. 2007, 5:4.
388. Jiang H.L., Xu C.X., Kim Y.K., Arote R., Jere D., Lim H.T., Cho M.H., Cho C.S. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 2009, 30:5844-5852.
389. Mandke R., Singh J. Cationic nanomicelles for delivery of plasmids encoding interleukin-4 and interleukin-10 for prevention of autoimmune diabetes in mice. Pharm. Res. 2012, 29:883-897.
390. Basarkar A., Singh J. Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice. Pharm. Res. 2009, 26:72-81.
391. Rosenberg S.A., Aebersold P., Cornetta K., Kasid A., Morgan R.A., Moen R., Karson E.M., Lotze M.T., Yang J.C., Topalian S.L., et al. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 1990, 323:570-578.
392. Gene therapy clinical trials worldwide http://www.wiley.com/legacy/wileychi/genmed/clinical/.
393. Noone P.G., Hohneker K.W., Zhou Z., Johnson L.G., Foy C., Gipson C., Jones K., Noah T.L., Leigh M.W., Schwartzbach C., Efthimiou J., Pearlman R., Boucher R.C., Knowles M.R. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. 2000, 1:105-114.
394. Bedikian A.Y., Richards J., Kharkevitch D., Atkins M.B., Whitman E., Gonzalez R. A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma. Melanoma Res. 2010, 20:218-226.
395. Sidi A.A., Ohana P., Benjamin S., Shalev M., Ransom J.H., Lamm D., Hochberg A., Leibovitch I. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J. Urol. 2008, 180:2379-2383.
396. Davis M.E., Zuckerman J.E., Choi C.H., Seligson D., Tolcher A., Alabi C.A., Yen Y., Heidel J.D., Ribas A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070.
397. El-Kamary S.S., Pasetti M.F., Mendelman P.M., Frey S.E., Bernstein D.I., Treanor J.J., Ferreira J., Chen W.H., Sublett R., Richardson C., Bargatze R.F., Sztein M.B., Tacket C.O. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J. Infect. Dis. 2010, 202:1649-1658.
398. Shi Q., Wang H., Tran C., Qiu X., Winnik F.M., Zhang X., Dai K., Benderdour M., Fernandes J.C. Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis. J. Biomed. Biotechnol. 2011, 2011:148763.
399. Raghuwanshi D., Mishra V., Das D., Kaur K., Suresh M.R. Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein. Mol. Pharm. 2012, 9:946-956.
400. Ekrami H.M., Shen W.C. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines. J. Drug Target. 1995, 2:469-475.
401. Lai W.F., Lin M.C. Nucleic acid delivery with chitosan and its derivatives. J. Control. Release 2009, 134:158-168.
402. Muzzarelli R.A. Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar. Drugs 2010, 8:292-312.
403. Shibata Y., Foster L.A., Metzger W.J., Myrvik Q.N. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect. Immun. 1997, 65:1734-1741.
404. Shibata Y., Foster L.A., Bradfield J.F., Myrvik Q.N. Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J. Immunol. 2000, 164:1314-1321.
405. Shibata Y., Honda I., Justice J.P., Van Scott M.R., Nakamura R.M., Myrvik Q.N. Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Infect. Immun. 2001, 69:6123-6130.
406. Strong P., Clark H., Reid K. Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Clin. Exp. Allergy 2002, 32:1794-1800.
407. Chew J.L., Wolfowicz C.B., Mao H.Q., Leong K.W., Chua K.Y. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 2003, 21:2720-2729.
408. Lee C.G., Da Silva C.A., Lee J.Y., Hartl D., Elias J.A. Chitin regulation of immune responses: an old molecule with new roles. Curr. Opin. Immunol. 2008, 20:684-689.
409. Da Silva C.A., Chalouni C., Williams A., Hartl D., Lee C.G., Elias J.A. Chitin Is a Size-Dependent Regulator of Macrophage TNF and IL-10 Production. J. Immunol. 2009, 182:3573-3582.
410. Reasor M.J., Hastings K.L., Ulrich R.G. Drug-induced phospholipidosis: issues and future directions. Expert Opin. Drug Saf. 2006, 5:567-583.
411. Tousignant J.D., Gates A.L., Ingram L.A., Johnson C.L., Nietupski J.B., Cheng S.H., Eastman S.J., Scheule R.K. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. Hum. Gene Ther. 2000, 11:2493-2513.
412. Ishida T., Ichihara M., Wang X., Yamamoto K., Kimura J., Majima E., Kiwada H. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J. Control. Release 2006, 112:15-25.
413. Boeckle S., von Gersdorff K., van der Piepen S., Culmsee C., Wagner E., Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med. 2004, 6:1102-1111.
414. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 2005, 11:990-995.
415. Hunter A.C., Moghimi S.M. Cationic carriers of genetic material and cell death: a mitochondrial tale. Biochim. Biophys. Acta 2010, 1797:1203-1209.
416. Li F., Liu W.G., Yao K.D. Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour. Biomaterials 2002, 23:343-347.
417. Park I.K., Jiang H.L., Cook S.E., Cho M.H., Kim S.I., Jeong H.J., Akaike T., Cho C.S. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: in vitro transfection. Arch. Pharm. Res. 2004, 27:1284-1289.
418. Lee D., Lockey R., Mohapatra S. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans. J. Nanosci. Nanotechnol. 2006, 6:2860-2866.
419. Mohammadi Z., Abolhassani M., Dorkoosh F.A., Hosseinkhani S., Gilani K., Amini T., Najafabadi A.R., Tehrani M.R. Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells. Int. J. Pharm. 2011, 409:307-313.
420. Oliveira H., Pires L.R., Fernandez R., Martins M.C., Simoes S., Pego A.P. Chitosan-based gene delivery vectors targeted to the peripheral nervous system. J. Biomed. Mater. Res. A 2010, 95:801-810.
421. Kumar A., Jena P.K., Behera S., Lockey R.F., Mohapatra S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine 2010, 6:64-69.
422. Midoux P., Monsigny M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjugate Chem. 1999, 10:406-411.
423. Terbojevich M., Cosani A., Focher B., Marsano E. High-performance gel-permeation chromatography of chitosan samples. Carbohydr. Res. 1993, 301-314.
424. Terbojevich M., Cosani A., Focher B., Naggi A., Torri G. Chitosans from Euphausia superba. 1: Solution properties. Carbohydr. Polym. 1992, 18:35-42.
425. Drogoz A., David L., Rochas C., Domard A., Delair T. Polyelectrolyte complexes from polysaccharides: Formation and stoichiometry monitoring. Langmuir 2007, 23:10950-10958.
426. Iqbal M., Lin W., Jabbal-Gill I., Davis S.S., Steward M.W., Illum L. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine 2003, 21:1478-1485.
427. Zhao Q.Q., Hu Y.L., Zhou Y., Li N., Han M., Tang G.P., Qiu F., Tabata Y., Gao J.Q. Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity. Int. J. Nanomed. 2012, 7:3191-3202.
428. Yang S.J., Chang S.M., Tsai K.C., Tsai H.M., Chen W.S., Shieh M.J. Enhancement of chitosan nanoparticle-facilitated gene transfection by ultrasound both in vitro and in vivo. J. Biomed. Mater. Res. B Appl. Biomater. 2012, 100:1746-1754.
429. Guo R., Xu S., Ma L., Huang A., Gao C. The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen-chitosan dermal equivalents. Biomaterials 2011, 32:1019-1031.
430. Kievit F.M., Veiseh O., Bhattarai N., Fang C., Gunn J.W., Lee D., Ellenbogen R.G., Olson J.M., Zhang M. PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection. Adv. Funct. Mater. 2009, 19:2244-2251.
431. Dass C.R., Contreras K.G., Dunstan D.E., Choong P.F. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007, 28:3026-3033.
432. Kim T.H., Jiang H.L., Nah J.W., Cho M.H., Akaike T., Cho C.S. Receptor-mediated gene delivery using chemically modified chitosan. Biomed. Mater. 2007, 2:S95-100.
433. Hussein Y.R., Sood A.K., Bandyopadhyay S., Albashiti B., Semaan A., Nahleh Z., Roh J., Han H.D., Lopez-Berestein G., Ali-Fehmi R. Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer. Hum. Pathol. 2012, 43:1638-1644.
434. Steg A.D., Katre A.A., Goodman B., Han H.D., Nick A.M., Stone R.L., Coleman R.L., Alvarez R.D., Lopez-Berestein G., Sood A.K., Landen C.N. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin. Cancer Res. 2011, 17:5674-5685.
435. Lu C., Han H.D., Mangala L.S., Ali-Fehmi R., Newton C.S., Ozbun L., Armaiz-Pena G.N., Hu W., Stone R.L., Munkarah A., Ravoori M.K., Shahzad M.M., Lee J.W., Mora E., Langley R.R., Carroll A.R., Matsuo K., Spannuth W.A., Schmandt R., Jennings N.B., Goodman B.W., Jaffe R.B., Nick A.M., Kim H.S., Guven E.O., Chen Y.H., Li L.Y., Hsu M.C., Coleman R.L., Calin G.A., Denkbas E.B., Lim J.Y., Lee J.S., Kundra V., Birrer M.J., Hung M.C., Lopez-Berestein G., Sood A.K. Regulation of tumor angiogenesis by EZH2. Cancer Cell 2010, 18:185-197.
436. Ghosn B., Singh A., Li M., Vlassov A.V., Burnett C., Puri N., Roy K. Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA. Oligonucleotides 2010, 20:163-172.
437. Han H.D., Mangala L.S., Lee J.W., Shahzad M.M., Kim H.S., Shen D., Nam E.J., Mora E.M., Stone R.L., Lu C., Lee S.J., Roh J.W., Nick A.M., Lopez-Berestein G., Sood A.K. Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin. Cancer Res. 2010, 16:3910-3922.
438. Cai Y.Q., Chen S.R., Han H.D., Sood A.K., Lopez-Berestein G., Pan H.L. Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats. J. Neurochem. 2009, 111:1000-1010.
439. Feng S., Agoulnik I.U., Truong A., Li Z., Creighton C.J., Kaftanovskaya E.M., Pereira R., Han H.D., Lopez-Berestein G., Klonisch T., Ittmann M.M., Sood A.K., Agoulnik A.I. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr. Relat. Cancer 2010, 17:1021-1033.
440. de Martimprey H., Bertrand J.R., Fusco A., Santoro M., Couvreur P., Vauthier C., Malvy C. siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res 2008, 36:e2.
441. Pille J.Y., Li H., Blot E., Bertrand J.R., Pritchard L.L., Opolon P., Maksimenko A., Lu H., Vannier J.P., Soria J., Malvy C., Soria C. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum. Gene Ther. 2006, 17:1019-1026.
442. Arbel J., Rozenbaum E., Reges O., Neuman Y., Levi A., Erel J., Haskia A.R., Caneti M., Sherf M., Mosseri M. USage of chitosan for Femoral (USF) haemostasis after percutaneous procedures: a comparative open label study. EuroIntervention 2011, 6:1104-1109.
443. U.N.I.o.Health ClinicalTrial.gov http://clinicaltrials.gov.
444. Malmquist J.P., Clemens S.C., Oien H.J., Wilson S.L. Hemostasis of oral surgery wounds with the HemCon Dental Dressing. Int. J. Oral Maxillofac. Surg. 2008, 66:1177-1183.
445. Jaffer S., Sampalis J.S. Efficacy and safety of chitosan HEP-40 in the management of hypercholesterolemia: a randomized, multicenter, placebo-controlled trial. Altern. Med. Rev. 2007, 12:265-273.
446. Gratieri T., Gelfuso G.M., Rocha E.M., Sarmento V.H., de Freitas O., Lopez R.F. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur. J. Pharm. Biopharm. 2010, 75:186-193.
447. Christensen K.S., Cohen A.E., Mermelstein F.H., Hamilton D.A., McNicol E., Babul N., Carr D.B. The analgesic efficacy and safety of a novel intranasal morphine formulation (morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model. Anesth. Analg. 2008, 107:2018-2024.
448. Kim J.K., Han K.H., Lee J.T., Paik Y.H., Ahn S.H., Lee J.D., Lee K.S., Chon C.Y., Moon Y.M. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin. Cancer Res. 2006, 12:543-548.
449. Huo Z., Sinha R., McNeela E.A., Borrow R., Giemza R., Cosgrove C., Heath P.T., Mills K.H., Rappuoli R., Griffin G.E., Lewis D.J. Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan. Infect. Immun. 2005, 73:8256-8265.
450. Aksungur P., Sungur A., Unal S., Iskit A.B., Squier C.A., Senel S. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J. Control. Release 2004, 98:269-279.
451. McNeela E.A., Jabbal-Gill I., Illum L., Pizza M., Rappuoli R., Podda A., Lewis D.J., Mills K.H. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine 2004, 22:909-914.